Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder

American Journal of Obstetrics and Gynecology - Tập 193 - Trang 352-360 - 2005
Meir Steiner1, Angelica Lindén Hirschberg2, Richard Bergeron3, Fiona Holland4, Michelle D. Gee4, Elisabeth Van Erp5
1Department of Psychiatry and Behavioural Neurosciences and Obstetrics and Gynecology, McMaster University, St Joseph's Hospital, Hamilton, Ontario, Canada
2Department of Obstetrics and Gynecology, Karolinska Hospital Stockholm, Sweden
3Ottawa Health Research Institute, Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada
4GlaxoSmithKline Pharmaceuticals, Harlow, United Kingdom
5Department of Obstetrics and Gynecology, Leyenburg Hospital, The Hague, The Netherlands

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

American Journal of Obstetrics and Gynecology

Tập 193

352-360

Thông tin tác giả